FFCP PHASE2:Hg19::chr6:6587418..6587427,-: Difference between revisions
From FANTOM5_SSTAR
Jump to: navigation, search
(Created page with "{{FFCP |DHSsupport=supported |DPIdataset=robust |EntrezGene= |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA |HGNC=HGNC:26593 |TSSclassifier=strong |UniProt= ...") |
No edit summary |
||
Line 4: | Line 4: | ||
|EntrezGene= | |EntrezGene= | ||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | |GencodeV16b_All_Build2_RSEM10_CPAT_consensus=gencodeV16_ncRNA | ||
|HGNC= | |HGNC=26593 | ||
|TSSclassifier=strong | |TSSclassifier=strong | ||
|UniProt= | |UniProt= |
Latest revision as of 13:11, 19 September 2015
Short description: | p8@LY86-AS1 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_8_at_LY86-AS1_5end |
Coexpression cluster: | C210_Burkitt_lymphoma_appendix_acute_diffuse_CD19_tonsil |
Association with transcript: | 0bp_to_ENST00000447858_5end |
EntrezGene: | NA |
HGNC: | 26593 |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p8@LY86-AS1 |
---|
0.0
0.5
1.0
1.5
2.0
2.5
3.0
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
lymphocyte of B lineage | 1.03e-17 | 24 |
pro-B cell | 1.03e-17 | 24 |
lymphoid lineage restricted progenitor cell | 6.99e-09 | 52 |
lymphocyte | 9.74e-09 | 53 |
common lymphoid progenitor | 9.74e-09 | 53 |
Showing 1 to 5 of 5 entries
Ontology term | p-value | n |
---|---|---|
lymphoma | 2.00e-40 | 10 |
hematologic cancer | 4.95e-09 | 51 |
immune system cancer | 4.95e-09 | 51 |
Showing 1 to 3 of 3 entries